Found 0 matching trials
Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder PHASE3 To evaluate the efficacy of ramelteon for treatment of acute depressive epi...
Show More Location
Multiple Locations
Learn More & Join Trial
Medication Maintenance Therapy in Community Pharmacy Settings EARLY_PHASE1 The goal of this study is to examine how the pharmacy can better optimize t...
Show More Location
Rhode Island Hospital
Learn More & Join Trial
Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Treated Opioid Dependent Population PHASE4 The primary objective of this study is to compare overall patient preferenc...
Show More Location
Hill Top Research
Learn More & Join Trial
Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder PHASE3 The study will assess efficacy, safety and tolerability of 0.5 mg/day and 1...
Show More Location
Birmingham Psychiatry
Learn More & Join Trial
Tolerability of SLIT With LAIS® Mites Allergoid Tablets N/A To expand knowledge on the application and tolerability of immunotherapy wi...
Show More Location
Multiple Locations
Learn More & Join Trial
A 3-Month Open-Label Safety and Efficacy Study of TNX-102 SL Tablets in Fibromyalgia Patients PHASE3 This is a Phase 3, open-label, extension trial designed to evaluate the lon...
Show More Location
Multiple Locations
Learn More & Join Trial
Neurocognitive Effects of Opiate Agonist Treatment PHASE4 The purpose of this study is to (1) compare the effects of buprenorphine an...
Show More Location
Fordham University
Learn More & Join Trial
The Efficacy and Safety of Edaravone Dexborneol Sequential Therapy in the Treatment of Patients With AIS PHASE3 SIM0308-302 is a multicenter, randomized, double-blind, placebo-controlled ...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05234) PHASE2 This study will evaluate the efficacy and safety of ragweed sublingual tabl...
Show More Location
Multiple Locations
Learn More & Join Trial
Monthly Versus Daily Buprenorphine Formulations for Treatment of Opiate Use Disorder PHASE4 Opioid use disorder and opioid-related deaths are increasing across Canada....
Show More Location
Royal Victoria Regional Health Centre
Learn More & Join Trial